Such methodological approach may have artificially reduced the impact of obesity on FABP4 levels as well as the magnitude of the association of any given FABP4 allelic variant with the degree of metabolic dysfunction or FABP4 plasma levels. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.